Actavis
Actavis
Actavis plc was a global pharmaceutical company that, after a series of mergers, became a part of the current company Allergan plc.
Overview
Originally based in Iceland, Actavis grew rapidly through both organic growth and acquisitions, eventually becoming one of the largest generic pharmaceutical companies in the world.
History
- 1956: Actavis was founded in Iceland as Pharmaco.
- 1999: The company was renamed Actavis following a merger.
- 2000s: Actavis experienced rapid growth and expansion, completing numerous acquisitions globally.
- 2015: Actavis completed the acquisition of Allergan, Inc., a transformative deal. Post-acquisition, the combined company adopted the name Allergan plc.
Notable Acquisitions
- Warner Chilcott: In 2013, Actavis acquired the specialty pharmaceutical company, enhancing its branded drug portfolio.
- Forest Laboratories: Acquired in 2014, this deal significantly expanded Actavis' branded drug business.
Key Products
Actavis had a vast product range that covered various therapeutic areas. Some of the most notable include:
- Generic formulations of blockbuster drugs.
- Specialty brand pharmaceuticals in areas such as women’s health, gastroenterology, and dermatology.
Facilities
Actavis had manufacturing, R&D, and commercial operations worldwide. Its facilities adhered to global quality standards and catered to both domestic and international markets.
Corporate Culture
Actavis was known for its dynamic culture, emphasizing innovation, growth, and a commitment to delivering high-quality pharmaceuticals to patients globally.
Controversies
The rapid growth of Actavis and its aggressive acquisition strategy did lead to certain criticisms, especially around issues of drug pricing and antitrust concerns.
See Also
References
- [1] "Actavis: Company History". Actavis Corporate Archive.
- [2] "Actavis and the Landscape of Generic Pharmaceuticals". Pharmaceutical Journal.
- [3] "Actavis Completes Allergan Acquisition". Financial Times.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
